Exploring the frontiers of penicillin pharmaceuticals: a comprehensive review of advancements and innovations

2026

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.51847/2m8klppg32
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Penicillin and its derivatives have remained a cornerstone in combating bacterial infections for decades. However, growing concerns about bacterial resistance and the limitations of conventional penicillin production methods underscore the need for innovative approaches. The aim of this review is to address the challenge of developing penicillin and related compounds by proposing a novel approach to improving the quality of medicines to meet healthcare demand. The discovery and optimization of m